+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      Effect of Volume Expansion on Nephrogenous Cyclic AMP during Vena Cava Constriction in the Dog

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Previous studies in our laboratory support the notion that an increase in the production of cyclic AMP (cAMP) by the kidney may play a role in the natriuresis of extracellular fluid volume expansion (ECVE). The present study was designed to evaluate whether a suppression in the rise in nephrogenous cAMP is involved in the blunted natriuretic response to ECVE during acute caval constriction. ECVE was produced by saline infusion in 8 thyropara-thyroidectomized dogs during acute constriction of the thoracic inferior vena cava and after its release. Arterial pressure decreased during caval constriction and ECVE and returned to values not different from control after the release of the constriction. There were no significant changes in renal plasma flow, glomerular filtration rate (GFR), fraction of filtered sodium excreted, or nephrogenous cAMP during the caval constriction. The release of the constriction in 4 dogs was followed by no significant changes in renal plasma flow and GFR, while the fraction of filtered sodium excreted increased significantly together with a significant rise in total nephrogenous cAMP by 1,682 ± 409 pmol/min (p < 0.05). The data are consistent with the hypothesis that the blunted natriuresis during ECVE in caval dogs is at least partly due to lack of increment in nephrogenous cAMP. The results provide further support for the role of renal cAMP in modulating renal handling of sodium.

          Related collections

          Author and article information

          S. Karger AG
          02 December 2008
          : 26
          : 2
          : 73-77
          Division of Nephrology, Department of Medicine, University of Southern California School of Medicine, Los Angeles, Calif.
          181955 Nephron 1980;26:73–77
          © 1980 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 5
          Original Paper


          Comment on this article